© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
This channel has partnered with the Brighteon Store and receives a small commission from all sales generated from an affiliate link.
Click the shop now button below to help out this channel.
The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients-A Large Population-Based Study
Ortal
Tuvali 1, Sagi Tshori 2, Estela Derazne 3, Rebecca Regina Hannuna 2,
Arnon Afek 3 4, Dan Haberman 1, Gal Sella 1, Jacob George 1
PMID: 35456309 PMCID: PMC9025013 DOI: 10.3390/jcm11082219
J Clin Med. 2022 Apr 15;11(8):2219. doi: 10.3390/jcm11082219.
Abstract
Myocarditis and pericarditis are potential post-acute
cardiac sequelae of COVID-19 infection, arising from adaptive immune
responses. We aimed to study the incidence of post-acute COVID-19
myocarditis and pericarditis. Retrospective cohort study of 196,992
adults after COVID-19 infection in Clalit Health Services members in
Israel between March 2020 and January 2021. Inpatient myocarditis and
pericarditis diagnoses were retrieved from day 10 after positive PCR.
Follow-up was censored on 28 February 2021, with minimum observation of
18 days. The control cohort of 590,976 adults with at least one negative
PCR and no positive PCR were age- and sex-matched. Since the Israeli
vaccination program was initiated on 20 December 2020, the time-period
matching of the control cohort was calculated backward from 15 December
2020. Nine post-COVID-19 patients developed myocarditis (0.0046%), and
eleven patients were diagnosed with pericarditis (0.0056%). In the
control cohort, 27 patients had myocarditis (0.0046%) and 52 had
pericarditis (0.0088%). Age (adjusted hazard ratio [aHR] 0.96, 95%
confidence interval [CI]; 0.93 to 1.00) and male sex (aHR 4.42; 95% CI,
1.64 to 11.96) were associated with myocarditis. Male sex (aHR 1.93; 95%
CI 1.09 to 3.41) and peripheral vascular disease (aHR 4.20; 95% CI 1.50
to 11.72) were associated with pericarditis.
Post COVID-19 infection was not associated with either myocarditis (aHR 1.08; 95% CI 0.45 to 2.56) or pericarditis (aHR 0.53; 95% CI 0.25 to 1.13). We did not observe an increased incidence of neither pericarditis nor myocarditis in adult patients recovering from COVID-19 infection.
Keywords: COVID-19; myocarditis; pericarditis.
https://pubmed.ncbi.nlm.nih.gov/35456309/
Mirrored - bootcamp





